PALOMINO LABORATORIES INC. Financing Cash Flow
PALOMINO LABORATORIES INC. (PALX) reported Financing Cash Flow of $14.82 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-05
- PALOMINO LABORATORIES INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $14.85M, a 789.28% increase year-over-year.
- PALOMINO LABORATORIES INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$30.00K, a 150100.00% decline year-over-year.
- PALOMINO LABORATORIES INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $1.12M, a 673.06% increase year-over-year.
- PALOMINO LABORATORIES INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $6.48M, a 32243.89% increase year-over-year.
- PALOMINO LABORATORIES INC. net cash provided by (used in) financing activities for fiscal 2025 was $9.27M, a 4644.11% increase from fiscal 2024.
- PALOMINO LABORATORIES INC. net cash provided by (used in) financing activities for fiscal 2024 was $195.44K, a 146.58% increase from fiscal 2023.
- PALOMINO LABORATORIES INC. net cash provided by (used in) financing activities for fiscal 2023 was $79.26K.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 10 month | Net Cash Provided by (Used in) Financing Activities 11 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $14.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $14.82M 10-Q · filed 2026-08-05 | $15.94M derived: sum of 3 quarters · filed 2026-08-05 | $22.42M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2026-03-31 | -$30.00K 10-Q · filed 2026-05-15 | $1.09M derived: sum of 2 quarters · filed 2026-05-15 | $7.57M derived: sum of 3 quarters · filed 2026-05-15 | $9.24M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $7.60M derived: sum of 2 quarters · filed 2026-03-31 | $9.27M derived: sum of 3 quarters · filed 2026-08-05 | $9.27M 10-K · filed 2026-03-31 | |||
| 2025-09-30 | $6.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $8.15M derived: sum of 2 quarters · filed 2026-08-05 | $8.15M 10-Q · filed 2025-11-14 | $8.30M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-06-30 | $1.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.67M 10-Q · filed 2026-08-05 | $20.00K 10-Q · filed 2025-08-07 | $1.81M derived: sum of 3 quarters · filed 2026-08-05 | $1.83M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-03-31 | $20.00 10-Q · filed 2026-05-15 | $144.77K derived: sum of 2 quarters · filed 2026-05-15 | $164.82K derived: sum of 3 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | $144.75K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $164.80K derived: sum of 2 quarters · filed 2025-03-28 | $195.44K 10-K · filed 2025-03-28 | ||||
| 2024-09-30 | $20.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $50.68K 10-Q · filed 2024-11-14 | |||||
| 2024-06-30 | $30.64K 10-Q · filed 2025-08-07 | ||||||
| 2023-12-31 | $56.77K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $153.20K 8-K · filed 2025-10-06 | $79.26K 10-K · filed 2025-03-28 | ||||
| 2023-09-30 | $22.49K 10-Q · filed 2024-11-14 | ||||||
| 2022-12-31 | $804.00 10-K · filed 2024-04-01 | ||||||
| 2022-09-30 | $304.00 10-Q · filed 2023-11-14 |